关键词：双相情感障碍；间歇性；情绪波动；狂热或极端；抑郁症；终身性疾病
摘 要：Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in the treatment of the disorder. It is considered a lifelong disease and the discontinuation of the medication can lead to the relapse of the condition
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Disease overview

Understanding the disorder

Types of bipolar disorder

Causes

Signs and symptoms

Management

Self-help

Epidemiology

PART 06: Pipeline analysis

ITI-007

FK949E

PROCYCLOX

RP5603

CNV1061436

LY2979165

DP-VPA

SKL-PSY

PGW-5

DLP-114

DLP-115

Small molecule targeting GPR78

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by drug class

Mood stabilizers

Anticonvulsants

Atypical antipsychotics

Antidepressant drugs

Anti-anxiety drugs

PART 09: Market segmentation by mechanism of action

Selective serotonin reuptake inhibitors

Serotonin-norepinephrine reuptake inhibitors

Tricyclic antidepressants

Monoamine oxidase inhibitors

Benzodiazepines

Beta blockers

Others

PART 10: Geographical segmentation

Global bipolar disorder therapeutics market by

geographical segmentation 2014-2019

Bipolar disorder therapeutics market in Americas

Bipolar disorder therapeutics market in EMEA

Bipolar disorder therapeutics market in APAC

PART 11: Market drivers

Increase in prevalence of bipolar disorder

High unmet need

Increase in R&D

PART 12: Impact of drivers

PART 13: Market challenges

Use of alternative therapies

Lack of availability of standard diagnostic methods

Limited awareness of disease

Increase in patent expiries

PART 14: Impact of drivers and challenges

PART 15: Market trends

Rise in public awareness

Patient assistance programs

Strategic alliances

PART 16: Vendor landscape

Competitive scenario

Market share analysis 2014

Other prominent vendors

PART 17: Key vendor analysis

Allergan

AstraZeneca

BMS

Eli Lilly

GSK

Janssen Pharmaceuticals

PART 18: Appendix

List of abbreviatios